
DvH Ventures launches Digital Health Fund
Dieter von Holtzbrinck Ventures (DvH Ventures) has announced the launch of its first Digital Health fund, which has held a first close on €60m.
The vehicle expects to hold a second close in the coming months, according to a statement, with investment from additional LPs.
The vehicle will back early-stage digital health startups.
DvH Ventures was founded in 2014 and focuses on early-stage startups in areas including financial technology, digital health and education.
Investors
The fund is currently backed by corporate investors and family offices. It has received commitments from pharmaceutical business Noventi, the Wort & Bild publishing group and the family office of pharmaceutical company Ursapharm. Wort & Bild is able to offer the fund's portfolio companies access to the readership of publications such as Die Zeit, Handelsblatt and Apotheken Umschau, according to a statement.
Investments
The fund will make investments in digital health startups, focusing on companies that it views as having innovative business models in the changing healthcare landscape. The fund will target startups involved in the local pharmacy sector in particular.
The vehicle will invest in early-stage and series-A rounds. DvH Ventures generally invests up to €2m per company.
People
Dieter von Holtzbrinck Ventures – Peter Richarz, Fabian von Trotha (managing partners).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater